GLP-1 is one of the important targets for the treatment of type 2 diabetes
Katzenstein AL, Bloor CM, Leibow AA
It supports the study of combined effects, optimal dosing for different injury types, timing protocols for acute versus chronic cases, and the link between reduced inflammation and tissue quality
Quick Answer: Zepbound begins working gradually after injection, with some patients noticing appetite changes within the first week, but clinically meaningful weight loss typically requires 4-12 weeks of consistent weekly dosing as the medication reaches steady-state levels and doses are increased
Some researchers experience injection site reactions including redness, swelling, or itching, which are typically mild and resolve on their own